Evidence map›Paper›PMID 39771025›Full record

ReviewNutrients2024

The Gut Microbiota's Role in Neurological, Psychiatric, and Neurodevelopmental Disorders.

Ioannis Alexandros Charitos, Angelo Michele Inchingolo, Laura Ferrante, Francesco Inchingolo, Alessio Danilo Inchingolo, Francesca Castellaneta, Antonella Cotoia, Andrea Palermo, Salvatore Scacco, Gianna Dipalma

Abstract readReview
In one paragraph

Review in Nutrients, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Low-Protein-Fed Chickens Benefit from ProbioticAnimals : an open access journal from MDPI · 2025
    Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ioannis Alexandros CharitosIstituti Clinici Scientifici Maugeri IRCCS, Pneumology and Respiratory Rehabilitation Unit, "Institute" of Bari, 70124 Bari, Italy.
Angelo Michele InchingoloInterdisciplinary Department of Medicine, University of Bari "Aldo Moro", 70124 Bari, Italy.ORCID 0000-0003-0104-6337
Laura FerranteInterdisciplinary Department of Medicine, University of Bari "Aldo Moro", 70124 Bari, Italy.ORCID 0009-0007-1494-3519
Francesco InchingoloInterdisciplinary Department of Medicine, University of Bari "Aldo Moro", 70124 Bari, Italy.ORCID 0000-0003-3797-5883
Alessio Danilo InchingoloInterdisciplinary Department of Medicine, University of Bari "Aldo Moro", 70124 Bari, Italy.ORCID 0000-0002-6366-1039
Francesca CastellanetaU.O.C. Immunohematology and Transfusion Medicine-S.I.M.T. Di Venere Hospital, 70131 Bari, Italy.ORCID 0000-0003-4555-5520
Antonella CotoiaDepartment of Intensive Care, University Hospital of Foggia, 71121 Foggia, Italy.ORCID 0000-0002-0154-0418
Andrea PalermoDepartment of Experimental Medicine, University of Salento, 73100 Lecce, Italy.
Salvatore ScaccoDepartment of Translational Biomedicine and Neuroscience (DiBraiN), Aldo Moro University, 70121 Bari, Italy.
Gianna DipalmaInterdisciplinary Department of Medicine, University of Bari "Aldo Moro", 70124 Bari, Italy.ORCID 0000-0002-5947-8987

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimThis article aims to explore the role of the human gut microbiota (GM) in the pathogenesis of neurological, psychiatric, and neurodevelopmental disorders, highlighting its influence on health and disease, and investigating potential therapeutic strategies targeting GM modulation. MATERIALS AND

methodsA comprehensive analysis of the gut microbiota's composition and its interaction with the human body, particularly, its role in neurological and psychiatric conditions, is provided. The review discusses factors influencing GM composition, including birth mode, breastfeeding, diet, medications, and geography. Additionally, it examines the GM's functions, such as nutrient absorption, immune regulation, and pathogen defense, alongside its interactions with the nervous system through the gut-brain axis, neurotransmitters, and short-chain fatty acids (SCFAs).

resultsAlterations in the GM are linked to various disorders, including Parkinson's disease, multiple sclerosis, depression, schizophrenia, ADHD, and autism. The GM influences cognitive functions, stress responses, and mood regulation. Antibiotic use disrupts GM diversity, increasing the risk of metabolic disorders, obesity, and allergic diseases. Emerging therapies such as probiotics, prebiotics, and microbiota transplantation show promise in modulating the GM and alleviating symptoms of neurological and psychiatric conditions.

conclusionsThe modulation of the GM represents a promising approach for personalized treatment strategies. Further research is needed to better understand the underlying mechanisms and to develop targeted therapies aimed at restoring GM balance for improved clinical outcomes.

Indexed as

Brain-Gut AxisGastrointestinal MicrobiomeMental DisordersNervous System DiseasesNeurodevelopmental DisordersProbioticsHumansPrebioticsPrebioticsautismgut–brain axisgut microbiota (GM)neuroinflammationneurological disordersprobiotics

Identifiers

PMID39771025
PMCPMC11677138

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.